Predictors, Disparities, and Facility-Level Variation: SGLT2 Inhibitor Prescription Among US Veterans With CKD.
L Parker GreggDavid J RamseyJulia M AkeroydShehrezade A JafryMichael E MathenySalim S ViraniSankar D NavaneethanPublished in: American journal of kidney diseases : the official journal of the National Kidney Foundation (2023)
Prescription for SGLT2 inhibitors was low among likely eligible patients, with evident disparities by sex and race and between individual VA facilities. Efforts are needed to study and address the reasons for these disparities to improve equitable adoption of these important medications.